Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/77679
Title: Indirubin derivative 7-bromoindirubin-3-oxime (7bio) attenuates aβ oligomer-induced cognitive impairments in mice
Authors: Chen, L
Huang, C
Shentu, J
Wang, M
Yan, S
Zhou, F
Zhang, Z
Wang, C
Han, Y 
Wang, Q
Cui, W
Issue Date: 2017
Publisher: Frontiers Media SA
Source: Frontiers in molecular neuroscience, 2017, v. 10,393 How to cite?
Journal: Frontiers in molecular neuroscience 
Abstract: Indirubins are natural occurring alkaloids extracted from indigo dye-containing plants. Indirubins could inhibit various kinases, and might be used to treat chronic myelocytic leukemia, cancer and neurodegenerative disorders. 7-bromoindirubin-3-oxime (7Bio), an indirubin derivative derived from indirubin-3-oxime, possesses inhibitory effects against cyclin-dependent kinase-5 (CDK5) and glycogen synthase kinase-3β (GSK3β), two pharmacological targets of Alzheimer’s disease (AD). In this study, we have discovered that 2.3–23.3 µg/kg 7Bio effectively prevented β-amyloid (Aβ) oligomer-induced impairments of spatial cognition and recognition without affecting bodyweight and motor functions in mice. Moreover, 7Bio potently inhibited Aβ oligomer-induced expression of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). Furthermore, 7Bio significantly prevented the decreased expression of synapsin-1 and PSD-95, biomarkers of pre-synaptic and post-synaptic proteins in Aβ oligomer-treated mice. The mean optical density (OD) with hyper-phosphorylated tau (pTau), glial fibrillary acidic protein (GFAP) and CD45 positive staining in the hippocampus of 7Bio-treated mice were significantly decreased compared to those of Aβ oligomer-treated mice. In addition, Western blotting analysis showed that 7Bio attenuated Aβ oligomer-decreased expression of pSer9-GSK3β. Those results suggested that 7Bio could potently inhibit Aβ oligomer-induced neuroinflammation, synaptic impairments, tau hyper-phosphorylation, and activation of astrocytes and microglia, which may contribute to the neuroprotective effects of 7Bio. Based on these findings, we expected that 7Bio might be developed as a novel anti-AD lead compound.
URI: http://hdl.handle.net/10397/77679
EISSN: 1662-5099
DOI: 10.3389/fnmol.2017.00393
Appears in Collections:Journal/Magazine Article

Access
View full-text via PolyU eLinks SFX Query
Show full item record

Page view(s)

1
Citations as of Sep 18, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.